Patient info Open main menu

Tixylix Chesty Cough – patient leaflet, side effects, dosage

Text from the MHRA, as of · About this document

Medicine status: No longer supplied Details

Medicine strength:
10 mg/ml
Contains active substance:

Patient leaflet - Tixylix Chesty Cough

1. WHAT ROBITUSSIN CHESTY COUGH JUNIOR / ROBITUSSIN CHESTY COUGH KIDS IS AND WHAT IT IS USED FOR

Robitussin Chesty Cough Junior / Robitussin Chesty Cough Kids is an oral solution for the relief of chesty coughs with associated hoarseness and sore

throat. It also helps to loosen mucus (catarrh) to make breathing easier. Each 5 ml dose of Robitussin Chesty Cough Junior / Robitussin Chesty Cough Kids contains 50 mg guaifenesin as the active ingredient.

This medicine is intended for use in children aged 6 to 10 years.

2. BEFORE YOU GIVE ROBITUSSIN CHESTY COUGH JUNIOR / ROBITUSSIN CHESTY COUGH KIDS

Do not give Robitussin Chesty Cough Junior / Robitussin Chesty Cough Kids

  • if your child is under 6 years of age.
  • if your child is allergic (hypersensitive) to any of the ingredients of this medicine (see Section 6).

Take special care with Robitussin Chesty Cough Junior / Robitussin Chesty Cough Kids

  • Robitussin Chesty Cough Junior / Robitussin Chesty Cough Kids is not recommended for use in children with hereditary fructose intolerance.

WARNING: Do not exceed the stated dose. Do not take with any other cough and cold medicine.

  • Consult a doctor before use if your child is suffering from an acute asthma attack, a chronic cough or is asthmatic.
  • Stop use and consult a healthcare professional if the cough persists after 5 days.
  • Stop use and consult a healthcare professional if the cough is accompanied by a fever, rash or persistent headache or is recurrent.

Taking other medicines

Please tell your doctor or pharmacist if your child is taking, or has recently taken, any other medicines, including medicines obtained without a prescription or if any tests are planned for a sample of your child's urine.

Robitussin Chesty Cough Junior / Robitussin Chesty Cough Kids should not be given at the same time as a cough suppressant.

Robitussin Chesty Cough Junior / Robitussin Chesty Cough Kids with food and drink

Robitussin Chesty Cough Junior / Robitussin Chesty Cough Kids may be given with or without food.

Pregnancy and breast-feeding

Ask your doctor or pharmacist for advice before taking any medicine.

This medicine is intended for use in children. There are no special precautions if this medicine is taken during pregnancy or when breast-feeding.

Driving and using machines

This medicine is intended for use in children. This medicine does not affect your ability to drive or operate machinery.

Important information about some of the ingredients of Robitussin Chesty Cough Junior / Robitussin Chesty Cough Kids.

This medicine contains 1 g of sorbitol per 5 ml dose, and is unsuitable for use in children with hereditary fructose intolerance. Robitussin Chesty Cough Junior / Robitussin Chesty Cough Kids also contains glycerol, sodium benzoate (E211)

and sweeteners (sodium saccharin and acesulfame potassium)

3. HOW TO GIVE ROBITUSSIN CHESTY COUGH JUNIOR / ROBITUSSIN CHESTY COUGH KIDS

Always give Robitussin Chesty Cough Junior / Robitussin Chesty Cough Kids exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure. Not to be used in children under 6 years of age. Seek medical advice before use for more than 5 days. Parents or carers should seek medical advice if the child's condition deteriorates during treatment. Shake well before use. Using the measuring spoon provided, the following doses may be given every 4 hours, by mouth, as required. Do not exceed 6 doses in 24 hours. After use, wipe the neck of the bottle clean and make sure the safety cap is properly closed.

Age Dose

6 to 10 years 5 ml to 10 ml (One to two spoonfuls 3-4 times a day)

If you give more Robitussin Chesty Cough Junior / Robitussin Chesty Cough Kids than you should

Giving your child too much Robitussin Chesty Cough Junior / Robitussin Chesty Cough Kids may cause nausea and vomiting. If you have accidentally given your child more medicine than you should, or if you suspect that your child has taken extra medicine, please contact your doctor. Take along the bottle and the label, and any medicine that is left.

If you forget to give Robitussin Chesty Cough Junior / Robitussin Chesty Cough Kids

Do not give your child a double dose to make up for a forgotten dose.

If you have any further questions on the use of this product, ask your doctor or pharmacist.

4. POSSIBLE SIDE EFFECTS

Like all medicines, Robitussin Chesty Cough Junior / Robitussin Chesty Cough Kids can cause side effects, although not everybody gets them.

If your child has any unwanted effects, such as nausea, vomiting or allergic reactions please tell your doctor or pharmacist. This includes any side effects not listed in this leaflet.

You can also report side effects directly via the Yellow Card Scheme at: ww.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine.

5. HOW TO STORE ROBITUSSIN CHESTY COUGH JUNIOR / ROBITUSSIN CHESTY COUGH KIDS

Keep out of the reach and sight of children.

Store below 25°C. Keep the container tightly closed.

Do not use Robitussin Chesty Cough Junior / Robitussin Chesty Cough Kids after the expiry date which is stated on the carton and the bottle label after <EXP>. The expiry date refers to the last day of that month.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.

6. FURTHER INFORMATION

What Robitussin Chesty Cough Junior / Robitussin Chesty Cough Kids contains

The active substance is guaifenesin.

The other ingredients are sodium benzoate (E211), sodium saccharin, glycerol, sorbitol solution (70%) (non-crystalline), citric acid monohydrate or anhydrous citric acid, blackcurrant flavour, vanilla flavour, acesulfame potassium, hydroxyethylcellulose, purified water.

What Robitussin Chesty Cough Junior / Robitussin Chesty Cough Kids looks like and contents of the pack

Robitussin Chesty Cough Junior / Robitussin Chesty Cough Kids is a colour-free oral solution. The following pack sizes are available, not all pack sizes may be marketed:

  • 100 ml amber-coloured glass bottle with either a tamper-evident cap or a child resistant cap. Measuring spoon provided.
  • 150ml amber-coloured glass bottle with either a tamper-evident cap or a child resistant cap. Measuring spoon provided.

Marketing Authorisation Holder

Haleon UK Trading Limited, Weybridge, KT13 0NY, U.K.

Manufacturer:

BCM Limited, Beeston, Nottinghamshire, NG90 2PR.

For any information about this medicinal product, please contact the Marketing Authorisation Holder. This leaflet was last approved in March 2024.

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 44673/0174

MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Tixylix Chesty Cough

Active substance Guaifenesin
Strength 10 mg/ml
Pharmaceutical form Oral solution
How is it taken Oral
Excipients Sodium benzoate, Sodium Saccharin, Glycerol, Sorbital solution (70%) (Non-cryst), Citric acid monohydrate or anhydrous citric acid Blackcurrant flavour DA13624, Vanilla flavour NN21166, Acesulfame Potassium, Hydroxyethylcellulose, Purified water
Is it available? No, all its packs are listed as discontinued (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 36 months.
Storage Store below 25°C.
Drug group (ATC)
  1. R Respiratory system drugs
    1. R05 Cough and cold preparations
      1. R05C Expectorants, excl. combinations with cough suppressants
        1. R05CA Expectorants
          1. R05CA03 guaifenesin
Marketing authorisation PL 44673/0174 (first authorised 18 January 2005)
Marketing authorisation holder Haleon UK Trading Limited
Codes BNF 03090200

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.1.0 of 12 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.